Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Artivion Inc AORT

Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment... see more

Recent & Breaking News (NYSE:AORT)

CryoLife to Participate in Upcoming Virtual Investor Conferences

PR Newswire August 6, 2020

CryoLife Reports Second Quarter 2020 Financial Results

PR Newswire July 30, 2020

CryoLife Announces Release Date and Teleconference Call Details for 2020 Second Quarter Financial Results

PR Newswire July 21, 2020

CryoLife Announces Pricing of $100 Million Convertible Senior Notes Offering

PR Newswire June 19, 2020

CryoLife Announces Offering of Convertible Senior Notes Due 2025

PR Newswire June 18, 2020

CryoLife Initiates Enrollment in PROACT Xa Clinical Trial

PR Newswire May 7, 2020

CryoLife Reports First Quarter 2020 Financial Results

PR Newswire April 30, 2020

CryoLife Announces Release Date and Teleconference Call Details for 2020 First Quarter Financial Results

PR Newswire April 16, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of CryoLife, Inc. - CRY

ACCESSWIRE IA April 2, 2020

CryoLife Provides Business Update in Response to COVID-19 Pandemic

PR Newswire April 1, 2020

CryoLife Receives CE Mark for E-vita Open NEO(TM) Hybrid Stent Graft

PR Newswire March 4, 2020

CryoLife Receives CE Mark for On-X® Ascending Aortic Prosthesis

PR Newswire February 27, 2020

CryoLife Reports Fourth Quarter and Full Year 2019 Financial Results

PR Newswire February 13, 2020

CryoLife Announces Release Date and Teleconference Call Details for 2019 Fourth Quarter and Year-end Financial Results

PR Newswire January 30, 2020

CryoLife Receives FDA Authorization to Commence PROACT Xa Clinical Trial

PR Newswire December 23, 2019

CryoLife and Misonix Enter Into Distribution Agreement for NeoPatch

PR Newswire December 19, 2019

CryoLife Receives CE Mark for E-nya Thoracic Stent Graft

PR Newswire December 2, 2019

CryoLife Receives CE Mark for E-nside Thoraco-abdominal Stent Graft

PR Newswire December 2, 2019

CryoLife Reports Third Quarter 2019 Financial Results

PR Newswire October 30, 2019

CryoLife Announces Release Date and Teleconference Call Details for 2019 Third Quarter Financial Results

PR Newswire October 16, 2019